Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Learn various ways to maximize credit card points for better rewards. This guide offers proven techniques to enhance your savings.
17,951 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A fresh review finds that a $10,000 investment in rsp’s equal-weight trap: $10,000 lagged a cap-weighted S&P 500 fund...
A coalition of twelve states filed a federal antitrust suit to block Paramount's $81 billion merger with Warner Bros....
A controversial proposal has sparked a fierce debate among developers, miners, and industry leaders. This article unp...
Frequency Electronics stock plummeting has traders watching closely. This guide breaks down the causes, what it means...
A new paid service promises ultra-fast access to high-profile Truth Social posts, including those from President Trum...
SpaceX faces another setback as a Starship test ends without a successful launch. This article breaks down the implic...
How do two AI infrastructure players compare when it comes to revenue scale? This article breaks down the factors, me...
In a year of sharp rotation, the Vanguard FTSE DEVELOPED Markets ETF ex US is outperforming the S&P 500—yet the decad...
PulteGroup accelerates its shift toward build-to-order homes to support margins as the 2026 housing market stays vola...
Occidental Petroleum surged after announcing a $5.8 billion debt reduction tied to the OxyChem sale and an uptick in ...
The U.S. economy posted 2.2% growth for 2025, a modest slowdown from 2024, with late-year softness in Q4. Consumers a...